-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On May 24, Sialon Pharmaceutical announced that the company's omeprazole sodium for injection passed the consistency evaluation of generic drugs.
The main indication for omeprazole sodium for injection that passed the generic drug consistency evaluation this time is for the treatment of acute upper gastrointestinal bleeding caused by duodenal ulcer, gastric ulcer, acute gastric mucosal lesions, and compound ulcers.
As a representative drug of proton pump inhibitors, omeprazole sodium for injection has the advantages of wide indications, high safety, and obvious pharmacoeconomic advantages compared with other similar drugs.